Medication use and risk of non-Hodgkin's lymphoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Epidemiology

• Publication date

  2005-11-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJE/KWI311PMID 16192343
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Body mass index and risk of malignant lymphoma in Scandinavian men and women.

  2005cited by this paper
• Regular use of aspirin or acetaminophen and risk of non-Hodgkin lymphoma

  2005cited by this paper
• Ultraviolet radiation exposure and risk of malignant lymphomas.

  2005influential reference
• Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women

  2004influential reference
• Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients.

  2004cited by this paper
• Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma

  2004cited by this paper
• Genetic determinants of the inflammatory response

  2004cited by this paper
• Lymphoproliferative disorders in autoimmune diseases in Japan: Analysis of clinicopathological features and Epstein‐Barr virus infection

  2004cited by this paper
• Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma.

  2003cited by this paper
• Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma.

  2003influential reference
• No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands)

  2003cited by this paper
• The epidemiology of autoimmune diseases.

  2003cited by this paper
• IARC Handbooks of Cancer prevention

  2003cited by this paper
• Association of aspirin and other non‐steroidal anti‐inflammatory drug use with incidence of non‐hodgkin lymphoma

  2003cited by this paper
• Population-based study of non-Hodgkin lymphoma, histology, and medical history among human immunodeficiency virus-negative participants in San Francisco.

  2003influential reference
• History of antibiotic use and risk of non‐Hodgkin's lymphoma (NHL)

  2003influential reference
• Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives.

  2003cited by this paper
• The use and resistance to antibiotics in the community.

  2003cited by this paper
• Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States)

  2002cited by this paper
• Chronic inflammation and cancer.

  2002cited by this paper
• Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

  2002cited by this paper
• Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells.

  2002cited by this paper
• Antibiotic Prescribing in Outpatients: a 1-Week Diagnosis-Prescribing Study in 5 Counties in Sweden

  2002cited by this paper
• Risk of non-Hodgkin lymphoma in celiac disease.

  2002cited by this paper
• The role of immunosuppression in lymphoma.

  2002cited by this paper
• Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.

  2002cited by this paper
• Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis.

  2002cited by this paper
• Differences in Antibiotic Prescribing Patterns Between General Practitioners in Scandinavia: A Questionnaire Study

  2002cited by this paper
• E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues

  2002influential reference
• A review of the genotoxicity of marketed pharmaceuticals.

  2001cited by this paper
• Digitoxin medication and cancer; case control and internal dose-response studies

  2001cited by this paper
• Rheumatic diseases and malignancy--is there an association?

  2001cited by this paper
• Chronic immune activation and inflammation as the cause of malignancy

  2001cited by this paper
• Haematopoietic cancer and medical history: a multicentre case control study

  2000cited by this paper
• Antidepressant medications and risk for cancer.

  2000cited by this paper
• Medical history and risk of Hodgkin's and non‐Hodgkin's lymphomas

  2000cited by this paper
• Non-steroidal anti-inflammatory drugs

  2000cited by this paper
• The rise in incidence of lymphomas in Europe 1985-1992.

  1999cited by this paper
• Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California.

  1999cited by this paper
• Use of human lymphoblastoid cells to detect the toxic effect of chloramphenicol and metabolites possibly involved in aplastic anemia in man.

  1997cited by this paper
• Medical history risk factors for non-Hodgkin's lymphoma in older women.

  1997cited by this paper
• Mechanistic studies on genotoxicity and carcinogenicity of salicylazosulfapyridine an anti-inflammatory medicine.

  1997cited by this paper
• Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma.

  1997cited by this paper
• Risks of Non‐Hodgkin's Lymphoma, Multiple Myeloma, and Leukemia Associated with Common Medications

  1996influential reference
• Antiepileptic treatment and risk for hepatobiliary cancer and malignant lymphoma.

  1995cited by this paper
• Bacterial infection as a cause of cancer.

  1995cited by this paper
• Relation of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver.

  1995cited by this paper
• Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis.

  1994cited by this paper
• Increasing incidence of non-Hodgkin's lymphoma.

  1993cited by this paper
• Simulation study of confounder-selection strategies.

  1993cited by this paper
• Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County.

  1992influential reference
• Lymphoma risks in populations with altered immunity--a search for mechanism.

  1992cited by this paper
• Primary immunodeficiencies: genetic risk factors for lymphoma.

  1992cited by this paper
• Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up.

  1989cited by this paper
• Use of antibiotics in general practice in Denmark in 1987.

  1989cited by this paper
• Immune-deficiency in Hodgkin's disease (HD): a study of patients and healthy relatives in families with multiple cases.

  1988cited by this paper
• Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences.

  1987cited by this paper
• Use of antibiotics in general practice in Denmark. Prescribed daily dose, duration of treatment and number of treatments in general practice.

  1986cited by this paper
• Cancer incidence in a cohort of patients with seizure disorders.

  1986cited by this paper
• Penicillin-induced leukopenia.

  1982cited by this paper
• Penicillin-induced leukopenia.

  1982cited by this paper
• Anticonvulsant drugs and cancer.

  1980cited by this paper
• Leukopenia due to penicillin and cephalosporin homologues.

  1979cited by this paper
• Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy.

  1979cited by this paper
• Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs.

  1979cited by this paper
• Malignant lymphoma after diphenylhydantoin (dilantin) therapy

  1975cited by this paper
• Malignant lymphoma associated with hydantoin drugs.

  1970cited by this paper

• The Effects of Antibiotics on the Development and Treatment of Non-Small Cell Lung Cancer

  2023cites this paper
• The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren’s syndrome: a single-centre, retrospective cohort study

  2023cites this paper
• Estimating the global burden of Epstein–Barr virus-related cancers

  2021cites this paper
• Characterization of environmental and genetic factors in multiple-case lymphoid cancer families

  2020cites this paper
• Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies

  2019cites this paper
• Sepsis and Risk of Cancer Among Elderly Adults in the United States

  2018cites this paper
• Comments on the Draft NTP Monograph on Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid (PFOA) or Perfluorooctane Sulfonate (PFOS) Comments on the Draft NTP Monograph on Immunotoxicity Associated with Exposure to Perfluorooctanoic Acid (PFOA) or Perfluorooctane Sulfonate (PFOS)

  2016cites this paper
• Lack of association between using aspirin and development of non-Hodgkins lymphoma: a meta-analysis.

  2015influential citation
• Common infection-related conditions and risk of lymphoid malignancies in older individuals

  2014influential citation
• Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs and Risk of Non-Hodgkin Lymphoma

  2013cites this paper
• Chronic inflammation, anti-inflammatory treatment and risk of malignant lymphomas

  2013cites this paper
• Inpatient Treatment of Community-Acquired Pneumonias with Integrative Medicine

  2013cites this paper
• Current Understanding of Lifestyle and Environmental Factors and Risk of Non-Hodgkin Lymphoma: An Epidemiological Update

  2012cites this paper
• Antibiotic use and risk of non‐hodgkin lymphomas

  2012cites this paper
• Multicentre hospital-based case-control study of diffuse large B-cell lymphoma in Shanghai, China.

  2012cites this paper
• Consumption of meat and dairy and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition

  2011cites this paper
• Malignant lymphoma associated with Behçet's disease: A report of 2 cases.

  2011cites this paper
• A Hospital-Based Case-Control Study of Non-Hodgkin Lymphoid Neoplasms in Shanghai: Analysis of Personal Characteristics, Lifestyle, and Environmental Risk Factors by Subtypes of the WHO Classification

  2010cites this paper
• A hospital-based case-control study of non-Hodgkin lymphoid neoplasms in Shanghai: analysis of environmental and occupational risk factors by subtypes of the WHO classification.

  2010cites this paper
• Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom.

  2009cites this paper
• Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case–control study

  2009cites this paper
• Common immune‐related risk factors and incident non‐Hodgkin lymphoma: The multiethnic cohort

  2009cites this paper
• A 69‐YEAR‐OLD MAN WITH LEFT HEMISPHERIC NECROTIZING MASS LESION

  2009cites this paper
• Die Rationale für Knochenmarkuntersuchungen bei Patienten mit entzündlich-rheumatischen Erkrankungen

  2009cites this paper
• The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies

  2008cites this paper
• Autoimmune disorders and lymphoma.

  2008cites this paper
• Tricyclic Antidepressants and Non-Hodgkin Lymphoma

  2008cites this paper
• Joint effect between regular use of non-steroidal anti-inflammatory drugs, variants in inflammatory genes and risk of lymphoma

  2008cites this paper
• Cyclooxygenase-2 independent effects of cyclooxygenase-2 inhibitors on oxidative stress and intracellular glutathione content in normal and malignant human B-cells

  2008cites this paper
• Antibiotic Use and the Risk of Lung Cancer

  2008cites this paper
• The non‐Hodgkin lymphomas: A review of the epidemiologic literature

  2007influential citation
• Primäres ZNS-Lymphom während der Behandlung von Autoimmunerkrankungen mit Azathioprin

  2007cites this paper
• Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case–control study

  2007influential citation
• [Primary CNS lymphoma in azathioprine therapy for autoimmune diseases: review of the literature and case report].

  2007cites this paper
• The safety of etanercept for the treatment of plaque psoriasis

  2007cites this paper
• Making sense of seasonal fluctuations in lymphoma diagnosis

  2007cites this paper
• Interaction between comorbidity and cancer.

  2007cites this paper
• Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors.

  2007cites this paper
• Use of nonsteroidal antiinflammatory drugs and non-Hodgkin lymphoma: a population-based case-control study.

  2006cites this paper
• Epidemiology and etiology of non-Hodgkin lymphoma – a review

  2006influential citation
• Nutrient intake and risk of non-Hodgkin's lymphoma.

  2006cites this paper
• Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype.

  2006cites this paper
• Malignant Lymphomas in Autoimmunity and Inflammation: A Review of Risks, Risk Factors, and Lymphoma Characteristics

  2006cites this paper
• of Association between Using Aspirin and Development of Non-Hodgkins Lymphoma: A Meta-analysis study

  year unknowninfluential citation